S.K. Health Care Formulations Private Limited, a active private limited company, was established on 22 September 2003 in Kakinada, East Godavari, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239AP2003PTC041738. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹3.65 Cr and a paid-up capital of ₹2.25 Cr.
It upholds a active non-compliant status. Employing 44 professional, Its leadership includes Aravind Galla (Additional Director), Raveendra Ganesh Mancham (Managing Director). Past directors included Sabita Manchem, Donthi Madhusudan Reddy. It holds ₹17.30 Cr open charges and ₹12.75 Cr settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at G1, Techno Castleroad No.1 L.B. Nagar, Kakinada, East Godavari, Andhra Pradesh, 533003.
U24239AP2003PTC041738
041738
22 September 2003
₹3.65 Cr
₹2.25 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into S.K. Health Care Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aravind Galla | Additional Director | 07 Nov 2020 | Current |
| Raveendra Ganesh Mancham | Managing Director | 22 Sep 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 06 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
S.K. Health Care Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.94% decrease. The company also saw a substantial fall in profitability, with a 45.92% decrease in profit. The company's net worth Soared by an impressive increase of 14.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to S.K. Health Care Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹173,000,000.00
₹127,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2025 | Axis Bank Limited | ₹4.90 Cr | Open |
| 03 Sep 2025 | Axis Bank Limited | ₹8.90 Cr | Open |
| 22 Mar 2025 | Sidbi | ₹2.00 Cr | Open |
| 22 Mar 2025 | Sidbi | ₹1.50 Cr | Open |
| 03 Jun 2010 | Central Bank Of India | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with S.K. Health Care Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of S.K. Health Care Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.K. Health Care Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited amounted to Rs. 4.90 Cr with Charge ID 101177866 was registered on 30 Oct 2025. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 8.90 Cr with Charge ID 101179457 was registered on 03 Sep 2025. was recorded as a recent event.
The activity A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 101067708 was registered on 22 Mar 2025. was completed.
Progress on A charge with Sidbi amounted to Rs. 1.50 Cr with Charge ID 101067701 was registered on 22 Mar 2025. was documented.
S.K. Health Care Formulations Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was recorded as a recent event.
Progress on S.K. Health Care Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was documented.
The CIN of S.K. Health Care Formulations Private Limited is U24239AP2003PTC041738.
S.K. Health Care Formulations Private Limited is headquartered at G1, Techno Castleroad No.1 L.B. Nagar, Kakinada, East Godavari, Andhra Pradesh, 533003.
S.K. Health Care Formulations Private Limited was incorporated on 22 September 2003.
The current directors of S.K. Health Care Formulations Private Limited are
The primary industry of S.K. Health Care Formulations Private Limited is Trade.
S.K. Health Care Formulations Private Limited is unlisted.
The authorized capital of S.K. Health Care Formulations Private Limited is ₹3.65 Cr, and the paid-up capital is ₹2.25 Cr.
The compliance status of S.K. Health Care Formulations Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX